The safety of combined administration of ultralow doses of antigens to endothelial NO synthase (impaza) and nitrates for the treatment of erectile dysfunction in CHD patients was evaluated in an open non-comparative clinical trial. The efficiency and safety of impaza and the possibility of its administration to patients receiving nitrates were demonstrated.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10517-009-0688-7 | DOI Listing |
Publication Analysis
Top Keywords
efficiency safety
8
safety combined
8
impaza nitrates
8
chd patients
8
erectile dysfunction
8
evaluation efficiency
4
combined treatment
4
treatment impaza
4
nitrates chd
4
patients erectile
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!